SUBGEN — Subgen AI AB Share News
0.000.00%
Last trade - 00:00- SEK39.52m
- SEK301.35m
- SEK204.39m
Brief: Aegirbio Gets SEK 100 Million Test Order
Brief: Aegirbio Prepares Change Of Listing To Nasdaq Stockholm Main List
Brief: Aegirbio: COVID-Test Approved In Germany By BfArM
Brief: Aegirbio Signs Agreement For Sale Of COVID-19 Tests In Germany
Brief: Aegirbio AB - Signs Distribution Agreement And Receives An Order
Brief: AegirBio Q4 Pretax Loss SEK 10.6 Mln
Brief: AegirBio Prelim FY Operating Loss At SEK 18.5 Mln
Brief: Aegirbio And Lifeassays Are Proposed To Be Merged
Brief: Aegirbio Gets Subsidy Of SEK 4.3 Mln From Eurostar
Brief: Aegirbio Q3 Pretax Loss At SEK 2.5 Mln
Brief: Aegirbio Starts FDA Fast Track Process With Its COVID-19 Test
Brief: Aegirbio's Covidtest Delivers Convincing Results In Italian And Swedish Studies
Brief: Aegirbio Signs R&D Agreement With MediaPharma
Brief: Aegirbio Acquires Viraspec
Brief: Aegirbio Reports Qtrly Shr Loss SEK 0.46
Brief: Aegirbio Launches New Strategy With A Long-Term Goal To Be Noted On Larger List